冯录召，研究员，博士生导师，病原体感染防控教育部重点实验室副主任，北京市人大教科文卫委员会副主任委员。兼任世界卫生组织新型流感疫苗全面价值评估咨询组专家，国家健康科普专家库成员，中华预防医学会旅行卫生专委会主任委员，北京预防医学会副会长。曾获省部级科技奖励8项，科普奖励2项。获得科技部科技基础资源调查专项、国家自然科学基金面上项目等项目资助。
      老虎机游戏引进人才，2020年加入老虎机游戏，曾在中国疾控中心工作。

长期从事传染病流行病学、智慧化监测预警、疫苗应用实施研究。系统评估流感、RSV等重点传染病疾病负担、严重性，揭示感染对慢病共病的影响和机制，定量评价疫苗及非药物干预措施效果，建立系列智慧化监测预警新方法和新技术。以通讯或第一作者（含并列）在Lancet、BMJ、Lancet Public Health、中华医学杂志等期刊发表160余篇论文。主编《传染病预防控制》教材和《漫画流感》等系列科普图书，参编7项WHO指南和立场文件。入选2023-2025年全球前2%顶尖科学家榜单。

老虎机游戏

1. 中国医学科学院老虎机游戏群医学及公共卫生学院,中国医药卫生文化协会疫苗与健康分会,《中国老年人群人呼吸道合胞病毒感染防控的关键问题专家共识》专家组. 中国老年人群人呼吸道合胞病毒感染防控的关键问题专家共识[J]. 中华预防医学杂志,2025,59(08)：1183-1195. DOI:10.3760/cma.j.cn112150-20250506-00391（通讯作者：冯录召,杨维中,雷正龙,许松涛）

2. Wu Z, Jiang M, Jia M, Sang J, Wang Q, Xu Y, Qi L*, Yang W*, Feng L*. The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children. Commun Biol. 2025 Jan 26;8(1):127. doi: 10.1038/s42003-025-07559-1.  (IF=5.1)

3. Li Y, Tong X, Jiang M, Wu Z, Duan Y, Zhang L, Lai S, Yang W, Feng L*. Chronic disease and infection in China: lessons from the covid-19 pandemic. BMJ. 2024 Oct 18;387:q2000. doi: 10.1136/bmj.q2000.  (IF=42.7)

4. Ma Y, Lu F, Suo L, Li W, Qian J, Wang T, Lv M, Wu J, Yang W, Guo M*, Li J*, Feng L*. Effectiveness of influenza vaccines in preventing acute cardiovascular events within 1 year in Beijing, China. NPJ Vaccines. 2024 Sep 28;9(1):177. doi: 10.1038/s41541-024-00969-y.  (IF=6.5)

5. Yang J*, Yang Z, Qi L, Li M, Liu D, Liu X, Tong S, Sun Q, Feng L*, Ou CQ, Liu Q*. Influence of air pollution on influenza-like illness in China: A nationwide time-series analysis. eBioMedicine. 2023 Jan;87:104421.  (IF=9.7)

6. Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou X-H *, Feng L*. Influenza’s plummeting during the COVID-19 pandemic: The roles of mask-wearing, mobility change, and SARS-CoV-2 interference. Engineering (Beijing). 2023 Feb;21:195-202.  (IF=10.1)

7. Feng L#, Zhang T#, Wang Q#, Xie Y, Peng Z, Zheng J, Qin Y, Zhang M, Lai S#, Wang D, Feng Z, LI Zhong, Gao GF. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021 May 31;12(1):3249.  (IF=17.69, C100, ESI)

8. He Z#, Ren L#, Yang J#, Guo L#, Feng L#, Ma C, Wang X, Leng Z, Tong X, Zhou W, Wang G, Zhang T, Guo Y, Wu C, Wang Q, Liu M, Wang C, Jia M, Hu X, Wang Y, Zhang X, Hu R, Zhong J, Yang J, Dai J, Chen L, Zhou X, Wang J, Yang W, Wang C. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet 2021; 397: 1075-84  (IF=202.73, C100, ESI)

9. Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, Lau YC, Zheng J, Feng S, Qin Y, Fang VJ, Jiang H, Lau EHY, Liu S, Qi J, Zhang J, Yang J, He Y, Zhou M, Cowling BJ, Feng L*, Yu H*. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health 2019, 4: e473-81. (IF=16.29, C100, ESI)

10. Yu H#, Cowling B J#, Feng L#, Lau E H#, Liao Q, Tsang T K, Peng Z, Wu P, Liu F, Fang V J, Zhang H, Li M, Zeng L, Xu Z, Li Z, Luo H, Li Q, Feng Z, Cao B, Yang W, Wu J T, Wang Y, and Leung G M. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013, 382(9887): 138-145.  (IF=39.21, C100)